NDC 67457-991 – Ogivri
Trastuzumab 150 mg/7.4mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC67457-991
Product details
- Brand name
- Ogivri
- Generic name
- trastuzumab
- Labeler
- Mylan Institutional LLC
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761074
- Marketed since
- November 29, 2019
- Marketing end
- February 28, 2027
- Pharmacologic class
- HER2/neu Receptor Antagonist
Active ingredients
- Trastuzumab 150 mg/7.4mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 67457-991-15 | 1 VIAL in 1 CARTON (67457-991-15) / 15 mL in 1 VIAL | Nov 29, 2019 |